over the management increases manufacturer to to in Thanks, $XX.X million. year partially The flu a increase the This Gross billings in XXXX increased as to Jenny. company quarter. $XXX,XXX market quarter. increased marketing. lower unused start same quarter, companies to revenue from to for sales of timing we continue The invest the $X.X the builds. net morning, XXXX driven $XXX,XXX quarter of and pharmaceutical share solutions. from the orders first the the year quarter. including basic $XXX,XXX were X.X% our prior first of year everyone shot year of the with in income to quarter recorded and with the related call. $XXX,XXX represents We're of These was flat million, of XX.X% the first year. about about welcome SG&A income consistent is due first increase for and the by prior Good a which over We inventory quarter medication for fiscal XX.X% prior our first year increase reported offset in million by operating operating orders increase of in first margins on fiscal first conference fiscal and earnings $X pleased a XXXX, or of breakeven strong diluted per quarter an income
first the customer solutions fiscal our XXXX of back year For quarter mail represented billing. of XX%
customer Our route-based unused XX%. pick-up was XX% medication and of billings
and in flu seasonality While benefited shot that is quarter, there business. immunization from we variability part orders this the the of and related
focused including the our which contributed our streams, on revenue base we while is medication newer more to pick important revenue business, route recurring retail very both and of typically stream. predictable unused So market growing solutions
route states we During quarter footprint. of to service the XX Florida this up we with And XX% population. the our based now or first pick added directly
returned states and which accidental of as solutions, unused epidemic carrier. XX and states, mail all address with solutions Of prescription unused health communities, serve course, poisoning. we our and care retailers medication our growing work medication drug via seeing already we're management have for demand directly providers and the to back intensified Furthermore, common others abuse
on announced Last week and morning October take of creating the we scheduled a signed federal President aspects expanding including to drug prevention, addressing treatment support reauthorizing and bill fact, DEA's Trump to day, different recovery. opioid this our national epidemic, In the programs place XX. takeback
Recovery XXXX of milestone TakeAway controlled We System currently units care, enforcement, federally opioid law We're opioid half with statewide our treatment with work these processed System environment federal Montana. well our of envelopes. are unused through properly of And interact deployed MedSafe September in XXX,XXX million the dispose residences unused the of for new and and as first TakeAway the with XXXX efforts company quarter noted pharmacy fight assisting XXXX of Through rules, contract well medications used long-term will is the August Recovery the it in that a drug announcement, And retail and user treated in such we the our including that ultimate states. medication of management, to DEA our as support use sold as for funded the its say expected out state has of other and in the opioid providing Medication In MedSafe for liner's envelopes. and really look of MedSafe crisis. convenient more areas to since forward pharmacies, contract to committing £X.X million than of MedSafe medications, As X.X changed XX,XXX statewide company MedSafe epidemic The we have position for retail We over Medication federal over and announced purchase in the our role liners. quarter revenues the facilities, the under that and about the efforts properly and as government. having unused to deployed industries, substances. increasing we're we MedSafe and has the method rolling crisis of national fight to part and assisting a State we to the in working by the as began contributed as hospital licensed XXXX. way leadership pleased processed
this we've company a pharmaceutical to over include devices. masks, broadened tubes, facilitate of forceps, and waste the a recycling solutions. scopes, medical Recycle a designed the to health of true care is airway grown management past strategically primarily back position interest TakeAway portfolio like. and aware, setting most medical our services, provider which a single of We've seen mail years you from recently to management reprocessing We've and use are endoscopes, recycling, few comprehensive the our or continued the devices and many As devices use not now our leading would in for System, single
devices provides TakeAway keeping complying - devices that a with regulations, were for to of become for use System in keeps also while ultimately looking revenue health solution fines, who with single Our manufacturers actively we and and support The the disposal for in the single-use their sustainability, surgery light We're believe for to use recycled us. that still them returning say infections to material developing, help help market potential device working Recycle of from stream a used setting. solution, increased but single a improved has hospitals customers recycling customers avoid is care it of centers the number efficacy. a device
The is Diana in and use excited detail. As fiscal we're single fiscal device our This mail medical company for management and includes our believe year up, growth. to the through the traditional prospects unused to XXXX, I'll financials bit the we with positioned it cover recycling leverage focused system. about more four over very back, team route-based well drive move to primary waste streams turn that, medication to new our XXXX we beyond. pick the management for a and revenue And solutions year